Account
iProspect named global media partner for Kering
Mumbai: iProspect, a dentsu company, has announced that it has been named global media partner for all Kering brands. As the global agency of record, iProspect will be responsible for managing all end-to-end media planning and buying for the luxury group, integrated across brand and performance, said the statement.
iProspect will operate as a media partner across all 42 markets where Kering has a media presence, and gradually take charge over Q1 2022, stated the agency.
The announcement follows a unique four-month agency review based on innovation principles and a fast-tracked process by the brand.
“The iProspect team’s digital and data-driven strategic vision and capabilities, its drive for innovation and creativity, along with its constant agile mindset. The group looks forward to working with iProspect within the fully integrated dentsu network as its unique partner, empowering the combination of a global vision and strong local expertise,” stated the Kering spokesperson, in reference to the pitch and subsequent selection.
The win builds on a year where dentsu re-launched iProspect as a new, future-focused, end-to-end global media agency.
“Enhancing our strong partnership with Kering is an amazing win for iProspect, one which propels our existing relationship onto a global stage,” said iProspect global brand president Amanda Morrissey. “As the end-to-end agency, with the full scope of Brand & Performance Media, our passionate team looks forward to working with one of the most innovative, digital-first, and data-driven luxury brands in the world.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
